XML 27 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Series A Preferred
Series B1 Preferred Stock
Series B Preferred Stock
Common Stock
Common Stock
Series A Preferred
Common Stock
Series B1 Preferred Stock
Common Stock
Series B Preferred Stock
Preferred Stock
Series A Preferred
Additional Paid-in Capital
Additional Paid-in Capital
Series B1 Preferred Stock
Additional Paid-in Capital
Series B Preferred Stock
Accumulated Deficit
Accumulated Deficit
Series B Preferred Stock
Non-controlling Interest
Balance at beginning (in shares) at Dec. 31, 2020         45,555,000       420,000            
Balance at beginning at Dec. 31, 2020 $ 5,925,000       $ 46,000       $ 0 $ 94,570,000     $ (90,009,000)   $ 1,318,000
Increase (Decrease) in Stockholders' Equity                              
Dividends on Series B and B1 Preferred Stock (372,000)                       (372,000)    
Accretion of discount on Series B and B1 Preferred Stock (507,000)                       (507,000)    
Conversion of B1 Preferred Stock to common (in shares)         7,722,000                    
Conversion of B1 Preferred Stock to common 12,045,000       $ 7,000         12,038,000          
Share based compensation expense $ 863,000                 863,000          
Exercise of options to common (in shares) 2,042,000       1,800,000   3,093,000                
Exercise of options / warrents $ 2,190,000   $ 16,405,000   $ 2,000   $ 3,000     2,188,000 $ 16,402,000        
Conversion of Series A Preferred stock to common stock (in shares)         (34,000)       (34,000)            
Conversion of Series B Preferred Stock to common stock (in shares)               5,084,000              
Conversion of Series B Preferred Stock to common stock       $ 13,194,000       $ 5,000       $ 12,559,000   $ 630,000  
Distribution to noncontrolling (169,000)                           (169,000)
Adjustment of redeemable noncontrolling interest to redemption value (1,992,000)                       (1,992,000)    
Contribution from noncontrolling interest (11,000)                           (11,000)
Net income (loss) (7,661,000)                       (18,364,000)   10,703,000
Less: amount attributable to redeemable non-controlling interest (9,844,000)                           (9,844,000)
Balance at end (in shares) at Dec. 31, 2021         63,288,000       386,000            
Balance at end at Dec. 31, 2021 30,066,000       $ 63,000       $ 0 138,620,000     (110,614,000)   1,997,000
Increase (Decrease) in Stockholders' Equity                              
Conversion of Series A Preferred stock to common stock   $ 1,000       $ 1,000                  
Conversion of Convertible Senior Notes to common (net of tax) (in shares)         10,165,000                    
Conversion of Convertible Senior Notes, net 59,822,000       $ 10,000         59,812,000          
Reclass of derivative liabilities 78,789,000                 78,789,000          
Adjustment of redeemable non controlling interest 0                 29,000     (29,000)    
Redemption of non-controlling interest 41,000                           41,000
Share based compensation expense $ 1,574,000                 1,574,000          
Exercise of options to common (in shares) 653,000       622,000   1,209,000                
Exercise of options / warrents $ 730,000   $ 0   $ 1,000   $ 1,000     729,000 $ (1,000)        
Conversion of Series A Preferred stock to common stock (in shares)           (386,000)     (386,000)            
Distribution to noncontrolling (380,000)                           (380,000)
Adjustment of redeemable noncontrolling interest to redemption value (428,000)                       (428,000)    
Net income (loss) 1,997,000                       (4,822,000)   6,819,000
Less: amount attributable to redeemable non-controlling interest (6,792,000)                           (6,792,000)
Balance at end (in shares) at Dec. 31, 2022         75,670,000       0            
Balance at end at Dec. 31, 2022 165,420,000       $ 76,000       $ 0 279,552,000     (115,893,000)   1,685,000
Increase (Decrease) in Stockholders' Equity                              
Conversion of Convertible Senior Notes to common (net of tax) (in shares)         17,206,000                    
Conversion of Convertible Senior Notes, net 101,130,000       $ 17,000         101,113,000          
Share based compensation expense $ 2,285,000                 2,285,000          
Issurance of restricted stock (in shares)         100,000                    
Exercise of options to common (in shares) 561,000       526,000                    
Exercise of options / warrents $ 683,000       $ 1,000         682,000          
Contribution from noncontrolling interest 2,842,000                           2,842,000
Net income (loss) (71,973,000)                       (71,486,000)   (487,000)
Balance at end (in shares) at Dec. 31, 2023         93,515,000       0            
Balance at end at Dec. 31, 2023 $ 200,387,000       $ 94,000       $ 0 $ 383,632,000     $ (187,379,000)   $ 4,040,000